WP
INBX icon

Woodline Partners’s Inhibrx INBX Stock Holding History

Woodline Partners’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38M Buy
400,892
+16,459
+4% +$1.65M 0.12% 233
2026
Q1 		$25.8M Buy
384,433
+244,954
+176% +$18.2M 0.1% 278
2025
Q4 		$11M Sell
139,479
-197,111
-59% -$13.4M 0.04% 434
2025
Q3 		$11.3M Sell
336,590
-326,278
-49% -$8.03M 0.05% 414
2025
Q2 		$9.46M Buy
662,868
+304,432
+85% +$3.94M 0.05% 444
2025
Q1 		$5.01M Buy
+358,436
New +$4.87M 0.03% 509

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners's INBX Position: Q2 2026 in Review

Woodline Partners increased its Inhibrx (INBX) stake by 4.3% in Q2 2026, buying an estimated $1.65M and bringing the position to 400,892 shares worth $38M. The position accounts for 0.12% of the portfolio, ranked #233.

Woodline Partners first reported a position in INBX in Q1 2025 and has held it in 6 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Woodline Partners held 400,892 shares of Inhibrx worth $38M as of Q2 2026.
  • Woodline Partners bought 16,459 Inhibrx shares in Q2 2026, an estimated $1.65M.
  • Inhibrx made up 0.12% of Woodline Partners's portfolio in Q2 2026, its #233 holding.
  • Woodline Partners first reported a position in Inhibrx in Q1 2025 and has held it in 6 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.